+ Follow CIBA GEIGY AND SANDOZ Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 210349
[Title] => No. 5 and eyeing no. 4
[Summary] => Three years since it was formed by the merger of Ciba Geigy and Sandoz. Novartis Healthcare Phils. now generates the fifth largest revenues in the local pharmaceutical and health case industry.
"We are behind United Laboratories, Glaxo-Smithkline, Pfizer, and Astra Zeneca," said Novartis country manager Leo Marchosky.
"We climbed up to the number five slot last year from number six, beating Roche."
[DatePublished] => 2003-06-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1125263
[AuthorName] => Angelica A. Angel
[SectionName] => Business As Usual
[SectionUrl] => business-as-usual
[URL] =>
)
)
)
CIBA GEIGY AND SANDOZ
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 210349
[Title] => No. 5 and eyeing no. 4
[Summary] => Three years since it was formed by the merger of Ciba Geigy and Sandoz. Novartis Healthcare Phils. now generates the fifth largest revenues in the local pharmaceutical and health case industry.
"We are behind United Laboratories, Glaxo-Smithkline, Pfizer, and Astra Zeneca," said Novartis country manager Leo Marchosky.
"We climbed up to the number five slot last year from number six, beating Roche."
[DatePublished] => 2003-06-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1125263
[AuthorName] => Angelica A. Angel
[SectionName] => Business As Usual
[SectionUrl] => business-as-usual
[URL] =>
)
)
)
abtest